📰 Sosei Group Chart News
Sosei Group Chart News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sosei Group Chart. Real-time updates on events, politics, business and more.
April 1, 2024
01.04.2024 - New name expresses the Company’s vision to lead the next era of medicine - from Japan, for Japan, and by extension, to the world – and its mission to accelerate the development of life-changing medicines, by investing in science and technologySosei ... Seite 1
February 16, 2024
16.02.2024 - Tokyo, Japan and Cambridge, UK, 16 February 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565), today announces that at a meeting held on 15 February 2024, its Board of Directors resolved to change the corporate names of ... Seite 1
February 13, 2024
13.02.2024 - Tokyo, Japan and Cambridge, UK, 13 February 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the 12 months ended 31 December 2023. The ... Seite 1
October 18, 2023
18.10.2023 - Tokyo, Japan, and Cambridge, UK, 18 October 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565), an international biopharmaceutical company and world-leader in GPCR-focused structure-based drug design (SBDD) and ... Seite 1
September 12, 2023
12.09.2023 - NBI-1117570 is an investigational, oral, muscarinic M1/M4 selective dual agonist discovered by Sosei Heptares that may have the potential to treat neurological and neuropsychiatric conditionsNBI-1117570 is the second compound to advance into ... Seite 1